Small Cap Stocks Worth Watching – March 17th

Tencent Music Entertainment Group, Direxion Daily MU Bull 2X Shares, Direxion Daily PLTR Bear 1X Shares, AltC Acquisition, bioAffinity Technologies, Lunai Bioworks, and Inflection Point Acquisition Corp. II are the seven Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations, typically roughly $300 million to $2 billion (definitions vary by index and data provider). They often offer higher growth potential but also tend to have greater volatility, lower liquidity, and higher risk compared with large-cap stocks, making them attractive for growth-oriented investors who can tolerate more risk. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Tencent Music Entertainment Group (TME)

Tencent Music Entertainment Group operates online music entertainment platforms to provide music streaming, online karaoke, and live streaming services in the People's Republic of China. It offers QQ Music, Kugou Music, and Kuwo Music that enable users to discover music in personalized ways; long-form audio content, including audiobooks, podcasts and talk shows, as well as music-oriented video content comprising music videos, live performances, and short videos; and WeSing, which enables users to sing along from its library of karaoke songs and share their performances in audio or video formats with friends.

Direxion Daily MU Bull 2X Shares (MUU)

Direxion Daily PLTR Bear 1X Shares (PLTD)

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

bioAffinity Technologies (BIAF)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.

Lunai Bioworks (LNAI)

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company’s lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase.

Inflection Point Acquisition Corp. II (IPXX)